For many years, small cell lung cancer (SCLC) has been staged using the Veterans Affairs classification system, which includes only 2 stages: limited (primary tumor and regional lymph nodes within a tolerable radiation field) and extensive (anything beyond limited stage).
Lung cancer remains the deadliest cancer, with more than 159,000 deaths and 220,000 newly diagnosed cases in 2011. Because treatment and survival are directly linked to disease stage, accurate staging in all patients is crucial.
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer.
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCLC).
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer.
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCLC).
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer.
This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer.
Facebook
X
LinkedIn
Forward
